arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

NATURES SUNSHINE PRODUCTS INC

NATR
$12.96 ▼ -0.25 (-1.89%) at close
Healthcare ·Pharmaceutical Preparations ·USPharmaceutical Preparations
68 Visible periods
34 Metrics
Peer-ranked Benchmarks
Price Chart
70
Health
Good
Neutral
auto_awesome

Analytical Summary

NATURES SUNSHINE PRODUCTS INC shows mixed fundamentals. Consider comparing against peers in the Healthcare sector before making investment decisions.

Market Cap $230.8M
Dividend Yield —
Revenue Growth 1.9% ↘
Op. Margin 4.7% ↘
ROIC None
FCF / Share $-0.11 ↗
Trailing P/E 64.8x
Price / Book —
FCF Yield —
Debt / Equity —
info Valuation on last close. End-of-day price, Sep 23, 2026.

68-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$116.98M
↑ +1.9% —
Net Income Profit after all expenses
$3.54M
↓ -33.7% —
Operating Margin Operating profit as % of sales
4.7%
↓ -39.7% 43th
FCF / Share Free cash flow per share
$-0.11
↑ +55.9% —
Long-Term Debt Long-term obligations
$2.11M
↑ +79.5% —

Health Breakdown

Profitability ↓
46
Financial Health ↑
97
Cash Quality ↑
79

Dividend History

Dividend / share · sourced from SEC filings
$0.00 Latest / share
-100.0% YoY

bar_chart Data from SEC EDGAR XBRL filings

Synced yesterday 18 years · 68 quarters